Geneos Wealth Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8
Closed -$1.11K 3171
2025
Q1
$1.11K Buy
+8
New +$1.24K ﹤0.01% 3040
2021
Q2
Sell
-12
Closed -$2K 2977
2021
Q1
$2K Buy
+12
New +$2.53K ﹤0.01% 2890
2020
Q1
Sell
-35
Closed -$6K 2543
2019
Q4
$6K Hold
35
﹤0.01% 2139
2019
Q3
$5K Hold
35
﹤0.01% 2096
2019
Q2
$8K Hold
35
﹤0.01% 1975
2019
Q1
$8K Hold
35
﹤0.01% 1904
2018
Q4
$7K Hold
35
﹤0.01% 1884
2018
Q3
$9K Hold
35
﹤0.01% 1874
2018
Q2
$10K Hold
35
﹤0.01% 1720
2018
Q1
$8K Sell
35
-5
-13% -$1.18K ﹤0.01% 1720
2017
Q4
$8K Hold
40
﹤0.01% 1703
2017
Q3
$7K Hold
40
﹤0.01% 1678
2017
Q2
$6K Hold
40
﹤0.01% 1678
2017
Q1
$6K Hold
40
﹤0.01% 1641
2016
Q4
$5K Hold
40
﹤0.01% 1626
2016
Q3
$5K Buy
+40
New +$4.82K ﹤0.01% 1570

Other funds holding ICUI

Geneos Wealth Management's ICUI Position: Q2 2025 in Review

Geneos Wealth Management sold out of ICU Medical (ICUI) in Q2 2025, closing a stake of 8 shares — an estimated $1.11K sold.

Geneos Wealth Management first reported a position in ICUI in Q3 2016 and held it in 16 quarters. The position peaked at $10K in Q2 2018. 271 funds tracked by Wall St. Rank hold ICUI as of Q2 2025.

  • Geneos Wealth Management reported no remaining ICU Medical position as of Q2 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 8 ICU Medical shares in Q2 2025, an estimated $1.11K.
  • Geneos Wealth Management first reported a position in ICU Medical in Q3 2016 and held it in 16 quarters.
  • Geneos Wealth Management's ICU Medical position peaked at $10K in Q2 2018.
  • 271 funds tracked by Wall St. Rank held ICU Medical as of Q2 2025.

Based on Geneos Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.